eCOA completion

92–98%

Typical diary completion

Retention uplift

+40%

With layered concierge support

Global readiness

120+

Languages supported

For pharma teams running global trials

Make Your Global Trials
Human.

Unified eCOA, validated wearable endpoints, and protocol-trained concierge support help pharma teams run decentralized and hybrid trials with confidence—while reducing site burden and preventing deviations early.

Book a Pharma Demo Talk to an Expert

Cleaner evidence · Fewer missed tasks · Faster issue resolution.

RISK
QC
SITE
PT

Trial Support + QC

Live monitoring · Site + patient coverage

Patient missed Day 14 diary — device sync pending.
Concierge outreach started. Device check in progress. Site notified if escalation needed.
QC flagged risk early — preventing a protocol deviation.
Human-in-the-loop Protocol-trained concierge coverage

The Modern Infrastructure for Global Drug Trials

Today’s trials generate millions of signals — but only actionable, validated endpoints move programs forward. Delve Health brings eCOA, wearables, and multilingual concierge together into a single, regulatory-aligned ecosystem.

Pharma digital platform

Built for Pharma Sponsors

Deploy globally, validate confidently, and keep evidence flowing—Delve combines eCOA, digital measures, consent, and analytics with a human layer that prevents drift and missed data.

Global Scale

Deploy multilingual eCOA + wearables across any region with consistent operations.

Regulatory Alignment

Fit-for-purpose validation and documentation designed for FDA/EMA review expectations.

Human Concierge

Real humans intervene when patients fall behind—recovering syncs and preventing deviations.

Real-Time Oversight

Live dashboards for safety signals, sync failures, and endpoint quality—without waiting for exports.

Unified eCOA + Wearables

Instead of juggling siloed vendors, Delve harmonizes subjective and objective data streams into a single real-time environment.

Wearables and eCOA

Retention Powered by Humans, Not Just Software

When a device misses a sync, a diary goes incomplete, or a patient feels lost — automation flags the issue, and our concierge team resolves it in minutes.

Patient concierge

Proven in Drug Development

Global Phase III Program

95% retention at 12 months with concierge + wearable oversight.

Digital Endpoint Validation

Objective signals correlated with gold-standard clinical measures.

Hybrid Oncology Study

63% improvement in adherence through patient outreach programs.

95%

Device Compliance

87%

Retention at 12 Months

60%

Fewer Missed Syncs

30%

Faster Enrollment Support

Run Your Next Global Trial With Confidence.

Real-time oversight. Validated digital endpoints. Human-centered retention.

Book a Pharma Demo